Inmune Bio Inc (INMB)

Dec 20, 2024

Charles Schwab Investment Management Inc. Trims Stock Holdings in INmune Bio, Inc. (NASDAQ:INMB) - Defense World

Dec 20, 2024

Dec 20, 2024

INmune Bio stock hits 52-week low at $4.44 amid market challenges - Investing.com Canada

Dec 20, 2024

Dec 20, 2024

INmune Bio stock hits 52-week low at $4.44 amid market challenges By Investing.com - Investing.com South Africa

Dec 20, 2024

Dec 16, 2024

Institutions along with retail investors who hold considerable shares inINmune Bio, Inc. (NASDAQ:INMB) come under pressure; lose 11% of holdings value - Simply Wall St

Dec 16, 2024

Dec 11, 2024

Learn to Evaluate (INMB) using the Charts - Stock Traders Daily

Dec 11, 2024

Dec 10, 2024

INmune Bio extends rights agreement to 2025 - Investing.com India

Dec 10, 2024

Dec 10, 2024

INmune Bio Inc. Completes Repayment of Silicon Valley Bank Debt - The Manila Times

Dec 10, 2024

Dec 10, 2024

INmune Bio Strengthens Balance Sheet Ahead of Crucial Alzheimer's Trial Data, Clears $15M Debt - StockTitan

Dec 10, 2024

Dec 09, 2024

INmune Bio extends rights agreement to 2025 By Investing.com - Investing.com Nigeria

Dec 09, 2024

Dec 09, 2024

Inmune Bio Announces Stock Options and Leadership Changes - TipRanks

Dec 09, 2024

Dec 04, 2024

OmniScience and INmune Bio Partner for Alzheimer’s Trial - Yahoo Finance

Dec 04, 2024

Dec 04, 2024

OmniScience Inc. and INmune Bio Inc. Partner to Accelerate - GlobeNewswire

Dec 04, 2024

Dec 04, 2024

INmune Bio Partners with OmniScience, Deploys GenAI Platform for Landmark Alzheimer's Trial - StockTitan

Dec 04, 2024

Nov 27, 2024

Elevai Labs, Inc. signed a license agreement to acquire a Worldwide License Agreement for Proprietary Stem Cell Manufacturing Technology from INmune Bio, Inc.. - Marketscreener.com

Nov 27, 2024

Nov 27, 2024

INmune Bio (NASDAQ:INMB) Trading 1.7% Higher – Should You Buy? - Defense World

Nov 27, 2024

Nov 27, 2024

INmune Bio (NASDAQ:INMB) Trading 1.7% HigherWhat's Next? - MarketBeat

Nov 27, 2024

Nov 20, 2024

Scotiabank Initiates Coverage of INmune Bio (INMB) with Sector Outperform Recommendation - MSN

Nov 20, 2024

Nov 19, 2024

INmune Bio stock hits 52-week low at $4.76 amid market challenges - Investing.com

Nov 19, 2024

Nov 19, 2024

(INMB) Trading Report - Stock Traders Daily

Nov 19, 2024

Nov 13, 2024

INmune Bio Inc. Announces Final Enrollment of 208 Patients in Phase 2 Trial in Early Alzheimer's Disease - Marketscreener.com

Nov 13, 2024

Nov 13, 2024

INmune Bio Hits Major Milestone: 208 Patients Enrolled in Phase 2 Alzheimer's Trial | INMB Stock News - StockTitan

Nov 13, 2024

Nov 13, 2024

Inmune Bio Emerges as Biotech Innovator in 2023 - TipRanks

Nov 13, 2024

Nov 05, 2024

INmune Bio, Inc. (NASDAQ:INMB) Q3 2024 Earnings Call Transcript - MSN

Nov 05, 2024

Nov 03, 2024

INmune Bio (NASDAQ:INMB) Releases Quarterly Earnings Results, Misses Estimates By $0.11 EPS - MarketBeat

Nov 03, 2024

Nov 03, 2024

Is INmune Bio (NASDAQ:INMB) Using Debt In A Risky Way? - Simply Wall St

Nov 03, 2024

Nov 03, 2024

INmune Bio Third Quarter 2024 Earnings: US$0.60 loss per share (vs US$0.48 loss in 3Q 2023) - Yahoo Finance UK

Nov 03, 2024

Nov 01, 2024

INmune Bio Inc (INMB) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges and ... - Yahoo Finance

Nov 01, 2024

Nov 01, 2024

Earnings call: INmune Bio Q3 2024 results show progress in clinical trials - Investing.com

Nov 01, 2024

Nov 01, 2024

INmune Bio Inc. Announces Third Quarter 2024 Results and Provides Business Update - The Manila Times

Nov 01, 2024

Nov 01, 2024

Inmune Bio Reports Increased Losses Amid Financing Efforts - TipRanks

Nov 01, 2024

Oct 31, 2024

INmune Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Oct 31, 2024

Oct 31, 2024

INmune Bio Q3 2024 Earnings Preview - MSN

Oct 31, 2024

Oct 31, 2024

Short Interest in INmune Bio, Inc. (NASDAQ:INMB) Increases By 5.6% - MarketBeat

Oct 31, 2024

Oct 30, 2024

INmune Bio Inc (INMB) Q3 2024 Earnings Report Preview: What To Look For - Yahoo Finance

Oct 30, 2024

Oct 28, 2024

INmune Bio Inc. to Host Webinar on Cognitive Testing Using EMACC and CDR-SB - The Manila Times

Oct 28, 2024

Oct 25, 2024

Highbridge Capital Management's Strategic Acquisition of INmune Bio Inc Shares - Yahoo Finance

Oct 25, 2024

Oct 25, 2024

INmune Bio (INMB) Scheduled to Post Quarterly Earnings on Thursday - MarketBeat

Oct 25, 2024

Oct 24, 2024

INmune Bio Says XPro1595 Promotes Remyelination, Key for Central Nervous System Diseases - MarketWatch

Oct 24, 2024

Oct 24, 2024

INmune Bio Inc. Announces Publication in Cell Reports Demonstrating XPro™ Promotes Remyelination - The Manila Times

Oct 24, 2024

Oct 24, 2024

INmune Bio Inc. to Report Third Quarter 2024 Financial Results and Provide Corporate Update on October 31, 2024 - The Manila Times

Oct 24, 2024

Oct 24, 2024

Insider Stock Buying Reaches US$951.2k On INmune Bio - Yahoo Finance

Oct 24, 2024

Oct 21, 2024

Alliance Global Partners Begins Coverage on INmune Bio (NASDAQ:INMB) - MarketBeat

Oct 21, 2024

Oct 20, 2024

Reviewing Windtree Therapeutics (NASDAQ:WINT) and INmune Bio (NASDAQ:INMB) - Defense World

Oct 20, 2024

Oct 18, 2024

(INMB) Technical Data - Stock Traders Daily

Oct 18, 2024

Oct 15, 2024

INmune Bio stock hits 52-week low at $4.8 amid market challenges - Investing.com

Oct 15, 2024

Oct 14, 2024

INmune Bio, Inc. (NASDAQ:INMB) Sees Large Decrease in Short Interest - MarketBeat

Oct 14, 2024